# Acrivon Therapeutics, Inc. Common Stock (ACRV)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ACRV/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -37.01M | $ -35.50M | $ 2.12M | $ 86.67M |
| 2025 | $ 0 | $ -79.77M | $ -66.90M | $ 2.71M | $ 112.52M |
| 2024 | $ 0 | $ -84.67M | $ -71.93M | $ 3.65M | $ 176.79M |
| 2023 | $ 0 | $ -65.29M | $ -47.50M | $ 4.64M | $ 121.20M |
| 2022 | $ 0 | $ -34.82M | $ -36.06M | $ 4.96M | $ 170.48M |
| 2021 | $ 0 | $ -8.06M | $ -7.22M | $ 5.63M | $ -23.81M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.14 |
| Current Ratio | 7.99 |

## Other views

- [Metrics](https://sponda.capital/en/ACRV.md)
- [Charts](https://sponda.capital/en/ACRV/charts.md)
- [Compare](https://sponda.capital/en/ACRV/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.